Ccla Investment Management / ABT
Ccla Investment Management’s Abbott Laboratories Position
Does Ccla Investment Management own Abbott Laboratories (ABT)? Yes — 845.7K shares worth $106M (+1.70% of its 13F portfolio) as of Q4 2025, down from 940.2K shares the prior filed quarter.
Position Value
$106M
Q4 2025
Shares
845.7K
% of Portfolio
+1.70%
Quarters Held
18
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 845.7K | $106M | +1.70% |
| Q3 2025 | 940.2K | $126M | +2.01% |
| Q2 2025 | 873.9K | $118.8B | +95.20% |
| Q1 2025 | 817.2K | $108M | +1.92% |
| Q4 2024 | 963.1K | $109M | +1.73% |
| Q3 2024 | 856.9K | $90M | +1.38% |
| Q2 2024 | 856.9K | $90M | +1.38% |
| Q1 2024 | 791.8K | $90M | +1.38% |
| Q4 2023 | 785.7K | $87M | +1.42% |
| Q3 2023 | 612.3K | $59M | +1.11% |
| Q2 2023 | 611.5K | $67M | +1.19% |
| Q1 2023 | 610.9K | $62M | +1.21% |
| Q4 2022 | 538.2K | $62M | +1.40% |
| Q3 2022 | 565.5K | $55M | +1.32% |
| Q1 2022 | 578.7K | $69M | +1.23% |
| Q4 2021 | 590.6K | $83M | +1.36% |
| Q3 2021 | 634.1K | $75M | +1.24% |
| Q2 2021 | 628.2K | $73M | +0.89% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ccla Investment Management’s full portfolio or all institutional holders of ABT.